Background: Hemodialysis is a metabolically stressful condition for patients that leads to reduced oxygen satu rati on and tissue perfusion. One of the identified drivers is a high ultrafiltration volume (UFV). Concurrently, central venous oxygen saturation (ScvO2) is a marker for global tissue hypoxia that has been used in cases of sepsis and trauma to guide fluid therapy. In dialysis patients with a central venous catheter (CVC) access ScvO2 is accessible. Here we intend to delineate the relationship of UFV to desaturation during dialysis through the measurement of ScvO2.
6 InaKidney EBCR InaKidney | Vol. II | Is. 1| Jan -Apr 2019 2 (DM type 2) with chronic diabetic complications. He was administered nicardipine 5mg/h which was raised to 10mg after 30 minutes and achieved SBP reduction of 25% by 1-hour, central venous access was procured using catheter double lumen (CDL) for emergency hemodialysis and his blood glucose was controlled. His hemodialysis regimen used bicarbonate dialysate, polyaryl etherosulfone (PAES) membrane with an ultrafiltration volume of 3,000 mL (cUFV: 44.1 mL/kgBW, 4.6% of interdialytic weight gain (IDWG)) and an ultrafiltration rate of 11mL/kg BW/h. During the initial dialysis session he complained of tiredness and shortness of breath, and his saturation fell to 92% with room air, which was alleviated by oxygen therapy of 3 liters/min. There was no co-occurrence of intradialytic hypotension (IDH) during continuous intradialytic blood pressure monitoring.
Subsequently, he underwent strict volume control and adjusted routine hemodialysis with CDL access for another two months before changing to an arteriovenous fistula. For his DM type 2, the regimen given was insulin aspart 4 unit tid and insulin glargine qDay 8 unit, and his hypertension was controlled by valsartan 40 mg bid PO and verapamil 80 mg tid PO. Additionally, his hemoglobin was sustained at above 10 g/dL without EPO or iron supplementation.
Background

Hemodialysis in chronic kidney disease (CKD) patients
has been understood to introduce hemodynamic stress to the patient. It has been demonstrated since 3 decades ago that during hemodialysis, oxygen saturation decreased and could occur as early as 15 minutes into the dialysis. 2-5 This phenomenon had been ascribed due to types of dialysate (acetate or bicarbonate), dialyzer membranes or respiratory pathologies; though none have been conclusive. 2,6-9 Identified inducers of organ ischemia had been ultrafiltration volume (UFV) and intradialytic hypotension (IDH); 10 UF causes non-physiological fluid shifts and IDH may be related to ensuing peripheral vasodilation and hypovolemia. Qualitatively, high UFV is defined as a volume exceeding the plasma refill volume; whilst there are no standard quantitative definitions of a high UFV, some assign the value to be ≥10ml/ kgBW/h or above 3 liters in 4 hours for average 70 kg man. 11,12 A well-described composite marker for oxygen saturation and global tissue oxygen extraction and delivery is central venous oxygen saturation (ScvO2); it has been used in the prognosis of trauma, post-surgical, acute coronary syndrome and sepsis. [13] [14] [15] In dialysis patients with catheter double lumen (CDL) access, ScvO2 is an accessible and simple parameter to monitor cardiac output and tissue oxygen delivery and extraction. 17 
Results
Search results can be seen in table 2-6.
Discussion
We summarized three studies based on our systematic ar- InaKidney | Vol. II | Is. 1| Jan -Apr 2019 Table 3 Critical appraisal of internal validity of the selected studies using CEBM Harm/Etiology Worksheet recruited and assessed their ScvO2 by means of blood gas analysis, they showed that pre-HD ScvO2 was 62.5±13% and post-HD 56.4±18%, with correlation ScvO2 decline to UFV was r: -0.680 (p: 0.015) and even stronger for corrected UFV to weight (cUFV), r: -0.769 (p: 0.003). They also validated the ScvO2 to venous pO2 pre-and post-HD with r: 0.78 and 0.92 respectively; both p<0.005). 18 The study by Zhang, et al., by the time this article was written, was Table 5 Studies' Critical Appraisal of their applicability using CEBM Harm/Etiology Worksheet This trend was evident in their sample population when the cUFV exceeded a cut-off point of 5mL/kg body weight.
They also pointed out that, a small subset of positive ScvO2 trend patients had a high cUFV and suggested that there was a possibility the cUFV, although high when compared to other samples, was actually too low compared to the interdialytic weight gain (IDWG) of the patients. This, in turn, reduced their UF-driven stress and allowed for the plasma refill rate to compensate and inhibited the occurrence of desaturation. 19 Rotondi, et al. assessed hypoxemia by measuring oxygen extraction ratio (OER), which was calculated from SaO2 and ScvO2. 20 They reported a stable SaO2 in their patients throughout the session, though the OER increased due to the drop in ScvO2. 20 They measured 20 patients for 4 sessions and found no significant OER changes to UFV, UFR, relative body volume (RBV) or blood pressure (BP); their UFR was kept below 10ml/kg BW/hr. Then, they divided the samples into iHD and iUF groups during the 5th and the 6th session of HD and reported a statistically significant ScvO2 decline in iHD group but not iUF. Analyzing the report along with supplemental data, the iUF arm also experienced ScvO2 decrease along with evidently incrementing OER and they reported non-difference of the ScvO2 decrease between iHD and iUF arms; it is more likely that the statistically insignificant decrease of venous oxygenation in iUF group was due to the small sample size of 10 patients. The authors suggested that the venous hypoxemia was more correlated with membrane biocompatibility or dialysate, of note the study used bicarbonate-buffered dialysate and PAES membrane. 20 Although some suspected acetate dialysate induced hypoxemia, studies showed there were statistically and clinically insignificant difference between acetate and bicarbonate di-
Assessing peripheral oxygen mismatch can be easily obtained by blood samples from the CVC which originates from the superior vena cava or right atrium, where the tip usually resides, thus reflecting ScvO2. 16 In turn, ScvO2 demonstrate cardiac output and upper body blood flow (UBBF), as it is determined by cardiac output, SaO2, organs that drain into superior vena cava and hemoglobin (Hb) levels. SaO2 has been reported to be stable or transiently decline but returning to normal by end of HD21 and Hb is elevated relatively during HD compared to pre-HD state, thus both unlikely to be the relative cause of decline.
Interdialytic weight gain is typically ≥3L, with circulating blood volume of 5-6L and 2L of which is plasma water, the volume removed during dialysis equate plasma volume.
Thus, as there is an imbalance of ultrafiltration and plasma refill rate there would be a decrease in cardiac preload and circulating volume. Dialysis patients suffer from a phenome non termed Bezold-Jarisch reflex, upregulation of parasympathetic and inhibition of sympathetic pathways due to activation in inhibitory cardiac receptors within the left ventricle causing, of importance, reflex bradycardia. 22 Paired with decreased preload and stroke volume, this results in the decline of cardiac output. These findings are reinforced by an intradialytic cardiac MRI study that displayed a negative relationship between UFV to cardiac index and stroke volume. 23, 24 The other possible driver of ischemia is IDH, defined as tients have been reported to be greater28. IDH may be a later signal towards progressively worsening tissue perfusion. UF-driven circulatory stress and hypoxemia in the longterm have been shown to elicit end-organ dysfunction, such as cardiac stunning, worsening cardiac failure and cognitive deficits. Intradialytic hypoxemia has also been proposed to be associated with all-cause hospitalization, mortality and increased obstructive sleep apnea (OSA) 10, 24, [29] [30] [31] These studies are admittedly not optimal as they are of small sample sizes or retrospective. There needs to be a large prospective cohort or randomized controlled trial (RCT) study to analyze continuous ScvO2 and UFV relationship. Study design by Rotondi, et al. allowed for a parallel control group with iHD group unexposed to ultrafiltration and iUF to ultrafiltration only. 20 Possibly, there would also be a need to assess ultrafiltration rate (UFR), as it has a negative circulatory effect and has a strong correlation with the incidence of hypoxemia as well. 16, 30 
Conclusion and Recommendation
These initial results show that UFV tends to be inversely proportionate to ScvO2, with ScvO2 starting to decline when cUFV is higher than 5ml/kgBW or more than 0.5% of IDWG. Further conclusive studies, such as RCTs, should be performed to provide a better quality of evidence. Additionally, ScvO2 decline is predictive of IDH and associated with long-term organ ischemia, hospitalization, and mortality. ScvO2 is a relatively simple and accessible method of monitoring in dialysis patients and should be used if possible, in high-risk patients.
